|

Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer

RECRUITINGSponsored by First Affiliated Hospital of Chongqing Medical University
Actively Recruiting
SponsorFirst Affiliated Hospital of Chongqing Medical University
Started2023-08-01
Est. completion2025-06-01
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06092450

Summary

Muscle invasive bladder cancer (MIBC) has a poor prognosis even after radical cystectomy. Postoperative survival stratification based on radiomics and deep learning may be useful for treatment decisions to improve prognosis. This study was aimed to develop and validate a deep learning radiomics model based on preoperative enhanced CT to predict postoperative survival in MIBC.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* patients with pathologically confirmed MIBC after radical cystectomy;
* contrast-CT scan less than two weeks before surgery;
* complete CT image data and clinical data.

Exclusion Criteria:

* patients who received neoadjuvant therapy;
* non-urothelial carcinoma;
* poor quality of CT images;
* incomplete clinical and follow-up data.

Conditions2

Bladder CancerCancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.